Inventor · disambiguated record
Arsenio Fialho
Also filed as: FIALHO ARSENIO · FIALHO ARSENIO M
22 granted patents·1 pending application·239 citations·filing 2005–2018
96Inventor score
Top patents by PatentIndex Score
23 records- 0197US7691383B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2005·Granted Apr 6, 2010·41 cites·32 claims
- 0296US7338766B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2006·Granted Mar 4, 2008·40 cites·8 claims
- 0396US7301010B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2006·Granted Nov 27, 2007·33 cites·23 claims
- 0495US7381701B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsUNIV ILLINOIS·Filed 2006·Granted Jun 3, 2008·24 cites·5 claims
- 0594US8530635B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2012·Granted Sep 10, 2013·10 cites·36 claims
- 0694US7807183B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2006·Granted Oct 5, 2010·23 cites·22 claims
- 0793US8206685B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2010·Granted Jun 26, 2012·9 cites·5 claims
- 0892US7511117B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2007·Granted Mar 31, 2009·16 cites·7 claims
- 0989US7740857B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2008·Granted Jun 22, 2010·7 cites·8 claims
- 1088US9161989B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Oct 20, 2015·4 cites·11 claims
- 1185US10058585B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofUNIV ILLINOIS·Filed 2015·Granted Aug 28, 2018·3 cites·8 claims
- 1284US9309292B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Apr 12, 2016·4 cites·19 claims
- 1384US8545812B2Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereofHONG CHANG SOO·Filed 2012·Granted Oct 1, 2013·6 cites·16 claims
- 1482US9096663B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofCHAUDHARI ANITA·Filed 2008·Granted Aug 4, 2015·4 cites·5 claims
- 1582US8623816B2Compositions and methods for treating malaria with cupredoxin and cytochromeCHAKRABARTY ANANDA·Filed 2007·Granted Jan 7, 2014·3 cites·2 claims
- 1681US10239920B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2015·Granted Mar 26, 2019·2 cites·10 claims
- 1779US9957304B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsCHAKRABARTY ANANDA·Filed 2008·Granted May 1, 2018·2 cites·8 claims
- 1878US10889621B2Compositions and methods for treating conditions related to ephrin signaling with CupredoxinsUNIV ILLINOIS·Filed 2018·Granted Jan 12, 2021·1 cites·13 claims
- 1978US8188251B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofHONG CHANG SOO·Filed 2010·Granted May 29, 2012·3 cites·6 claims
- 2076US7795410B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2009·Granted Sep 14, 2010·3 cites·17 claims
- 2168US10266868B2Compositions for treating HIV infection with cupredoxin and cytochrome CCHAKRABARTY ANANDA·Filed 2010·Granted Apr 23, 2019·1 cites·7 claims
- 2256US10072049B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2016·Granted Sep 11, 2018·0 cites·8 claims
- 2333US2010278937A1Compositions and methods to prevent and/or treat cancer with pa-cardDAS GUPTA TAPAS K·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →